Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy-Reference-Cited by-同舟云学术

Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy

Published:2013-10 Issue:5 Volume:22 Page:919-925
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Feldman-Stewart Deb,Madarnas Yolanda,Mates Mihaela,Tong Christine,Grunfeld Eva,Verma Shailendra,Carolan Hannah,Brundage Michael

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference40 articles.

1. Breast cancer incidence and mortality worldwide in 2008;International Agency For Research on Cancer WHO,2008

2. Canadian cancer statistics 2011;Canadian Cancer Society, Public Health Agency Of Canada, Statistics Canada,2011

3. Controversies in adjuvant endocrine therapy for pre- and post-menopausal women with breast cancer;Ciccarese;EJC Supplements,2008

4. The role of aromatase inhibitors in adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: guideline recommendations. Evidence-based series #1–18: section 1, 1–9;Eisen,2008

5. Advances in adjuvant endocrine therapy for postmenopausal women;Lin;J Clin Oncol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Views of stakeholders on factors influencing shared decision-making in the Eastern Mediterranean Region: a systematic review;Eastern Mediterranean Health Journal;2021-03-23

2. Willingness of Women with Early Estrogen Receptor–Positive Breast Cancer to Take Adjuvant CDK4/6 Inhibitors;Current Oncology;2020-06-01

3. Lessons Learned from a Cancer Knowledge Translation Grants Program: Results of an Evaluation;Current Oncology;2019-08-01

4. Treatment Decisions and Adherence to Adjuvant Endocrine Therapy in Breast Cancer;Current Breast Cancer Reports;2017-04-27

5. Shared decision-making and providing information among newly diagnosed patients with hematological malignancies and their informal caregivers: Not “one-size-fits-all”;Psycho-Oncology;2017-04-17